Lv4
650 积分 2023-08-03 加入
Molecular and clinicopathological characteristics of invasive breast cancers with HER2-ultralow expression
29天前
已完结
Genomic and transcriptomic landscape of HER2-low breast cancer
29天前
已完结
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study
1个月前
已完结
Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients
1个月前
已完结
Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype
1个月前
已完结
Immunopathologic Assessment of PTEN Expression
5个月前
已完结
Structural prediction, whole exome sequencing and molecular dynamics simulation confirms p.G118D somatic mutation of PIK3CA as functionally important in breast cancer patients
9个月前
已完结
[Consensus on clinical diagnosis and treatment of breast cancer with low expression of human epidermal growth factor receptor 2 (2022 edition)]
10个月前
已完结
[Guideline for HER2 testing in breast cancer (2024 version)]
10个月前
已完结
[Guidelines for diagnosis and treatment of advanced breast cancer in China (2024 edition)]
10个月前
已完结
皖公网安备34019202002308
